Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Popper, H; Stacher-Priehse, E; Brcic, L; Nerlich, A.
Lung fibrosis in autoimmune diseases and hypersensitivity: how to separate these from idiopathic pulmonary fibrosis.
Rheumatol Int. 2022; 42(8):1321-1330
Doi: 10.1007/s00296-021-05002-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Popper Helmuth
- Co-authors Med Uni Graz
- Brcic Luka
- Stacher-Priehse Elvira
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Lung involvement in autoimmune diseases (AID) is uncommon, but may precede other organ manifestations. A diagnostic problem is chronicity presenting with lung fibrosis. A new category of interstitial pneumonia with autoimmune features for patients with clinical symptoms of AID and presenting with usual interstitial pneumonia (UIP) enables antifibrotic treatment for these patients. Hypersensitivity pneumonia (HP) and other forms of lung fibrosis were not included into this category. As these diseases based on adverse immune reactions often present with unspecific clinical symptoms, a specified pathological diagnosis will assist the clinical evaluation. We aimed to establish etiology-relevant differences of patterns associated with AID or HP combined with lung fibrosis. We retrospectively evaluated 51 cases of AID, and 29 cases of HP with lung fibrosis, and compared these to 24 cases of idiopathic pulmonary fibrosis (UIP/IPF). Subacute AID and HP most often presented with organizing pneumonia (OP), whereas chronicity was associated with UIP. Unspecified fibrosis was seen in a few cases, whereas NSIP pattern was rare. In 9 cases, the underlying etiology could not be defined. Statistically significant features differentiating chronic AID or HP from UIP/IPF are lymphocytic infiltrations into myofibroblastic/fibroblastic foci. Other features significantly associated with AID and HP were granulomas, isolated Langhans giant cells, and protein deposits, but seen in only a minority of cases. A combination of UIP with one of these features enabled a specific etiology-based diagnosis. Besides the antifibrotic drug regimen, additional therapies might be considered.
- Find related publications in this database (using NLM MeSH Indexing)
- Alveolitis, Extrinsic Allergic - diagnosis, etiology
- Autoimmune Diseases - complications, diagnosis
- Diagnosis, Differential - administration & dosage
- Humans - administration & dosage
- Idiopathic Pulmonary Fibrosis - diagnosis, pathology
- Lung - pathology
- Retrospective Studies - administration & dosage
- Find related publications in this database (Keywords)
- Fibrosing pneumonia
- Chronic autoimmune disease
- Rheumatoid arthritis
- Systemic sclerosis
- Sjogren syndrome
- Systemic lupus
- Chronic hypersensitivity pneumonia
- UIP
- IPF